UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number000-23544
HUMAN PHEROMONE SCIENCES, INC.
(Exact name of registrant as specified in its charter)
| California | 94-3107202 | |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
| 84 West Santa Clara Street, San Jose, California | 95113 | |
| (Address of principal executive offices) | (Zip code) |
Registrant’s telephone number:(408) 938-3030
Common Stock
(Title of each class of securities covered by this Form)
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) | ¨ |
| Rule 12g-4(a)(2) | ¨ |
| Rule 12h-3(b)(1)(i) | ¨ |
| Rule 12h-3(b)(1)(ii) | x |
| Rule 15d-6 | ¨ |
Approximate number of holders of record as of the certification or notice date:
487
Pursuant to the requirements of the Securities Exchange Act of 1934(Name of registrant as specified in charter)has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: March 30, 2012 | /s/ William P. Horgan |
| William P. Horgan | |
| Chairman and Chief Executive Officer | |
| (Principal Executive Officer) |
